Researchers have withdrawn three substudies of the anti-cholesterol drug Lipitor, after Pfizer – the company that both manufactures the drug and sponsored the clinical trial – discovered an error.
A story in Forbes says blood samples from the study had been matched to the wrong participants. According to story, the study results had been published in the New England Journal of medicine in 2005. They had a major impact on clinical ...
continue reading...